Eden Biodesign Ltd. has been licensed by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to manufacture Investigational Medicinal Products (IMPs) at its new facility in Liverpool, UK. The UK National Biomanufacturing Centre came on-line for process and analytical development in May 2006. The MHRA inspection took place earlier this year to certify Eden’s processes and facilities as having reached cGMP standards. The new license will provide legal authority for Eden to manufactur...